Literature DB >> 14512538

Positive and negative modulation of virus infectivity and envelope glycoprotein incorporation into virions by amino acid substitutions at the N terminus of the simian immunodeficiency virus matrix protein.

Julieta M Manrique1, Cristina C P Celma, Eric Hunter, José L Affranchino, Silvia A González.   

Abstract

The matrix (MA) protein of the simian immunodeficiency viruses (SIVs) is encoded by the amino-terminal region of the Gag precursor and is the component of the viral capsid that lines the inner surface of the virus envelope. Previously, we identified domains in the SIV MA that are involved in the transport of Gag to the plasma membrane and in particle assembly. In this study, we characterized the role in the SIV life cycle of highly conserved residues within the SIV MA region spanning the two N-terminal alpha-helices H1 and H2. Our analyses identified two classes of MA mutants: (i) viruses encoding amino acid substitutions within alpha-helices H1 or H2 that were defective in envelope (Env) glycoprotein incorporation and exhibited impaired infectivity and (ii) viruses harboring mutations in the beta-turn connecting helices H1 and H2 that were more infectious than the wild-type virus and displayed an enhanced ability to incorporate the Env glycoprotein. Remarkably, among the latter group of MA mutants, the R22L/G24L double amino acid substitution increased virus infectivity eightfold relative to the wild-type virus in single-cycle infectivity assays, an effect that correlated with a similar increase in Env incorporation. Furthermore, the R22L/G24L MA mutation partially or fully complemented single-point MA mutations that severely impair or block Env incorporation and virus infectivity. Our finding that the incorporation of the Env glycoprotein into virions can be upregulated by specific mutations within the SIV MA amino terminus strongly supports the notion that the SIV MA domain mediates Gag-Env association during particle formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512538      PMCID: PMC224977          DOI: 10.1128/jvi.77.20.10881-10888.2003

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Identification of two neutralizing and 8 non-neutralizing epitopes on simian immunodeficiency virus envelope using monoclonal antibodies.

Authors:  K A Kent; E Rud; T Corcoran; C Powell; C Thiriart; C Collignon; E J Stott
Journal:  AIDS Res Hum Retroviruses       Date:  1992-06       Impact factor: 2.205

2.  Gag proteins of the highly replicative MN strain of human immunodeficiency virus type 1: posttranslational modifications, proteolytic processings, and complete amino acid sequences.

Authors:  L E Henderson; M A Bowers; R C Sowder; S A Serabyn; D G Johnson; J W Bess; L O Arthur; D K Bryant; C Fenselau
Journal:  J Virol       Date:  1992-04       Impact factor: 5.103

3.  The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.

Authors:  X Yu; X Yuan; Z Matsuda; T H Lee; M Essex
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Mutations in the N-terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor.

Authors:  X Yuan; X Yu; T H Lee; M Essex
Journal:  J Virol       Date:  1993-11       Impact factor: 5.103

5.  Mutations in the cytoplasmic domain of human immunodeficiency virus type 1 transmembrane protein impair the incorporation of Env proteins into mature virions.

Authors:  X Yu; X Yuan; M F McLane; T H Lee; M Essex
Journal:  J Virol       Date:  1993-01       Impact factor: 5.103

6.  Assembly of the matrix protein of simian immunodeficiency virus into virus-like particles.

Authors:  S A González; J L Affranchino; H R Gelderblom; A Burny
Journal:  Virology       Date:  1993-06       Impact factor: 3.616

7.  Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  T Dorfman; F Mammano; W A Haseltine; H G Göttlinger
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

8.  Truncation of the human immunodeficiency virus type 1 transmembrane glycoprotein cytoplasmic domain blocks virus infectivity.

Authors:  J W Dubay; S J Roberts; B H Hahn; E Hunter
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

9.  Sequence analysis and acute pathogenicity of molecularly cloned SIVSMM-PBj14.

Authors:  S Dewhurst; J E Embretson; D C Anderson; J I Mullins; P N Fultz
Journal:  Nature       Date:  1990-06-14       Impact factor: 49.962

10.  Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids.

Authors:  W Zhou; L J Parent; J W Wills; M D Resh
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  11 in total

1.  Multiple Gag domains contribute to selective recruitment of murine leukemia virus (MLV) Env to MLV virions.

Authors:  Devon A Gregory; Terri D Lyddon; Marc C Johnson
Journal:  J Virol       Date:  2012-11-14       Impact factor: 5.103

2.  Amino acid residues in the cytoplasmic domain of the Mason-Pfizer monkey virus glycoprotein critical for its incorporation into virions.

Authors:  Chisu Song; Keith Micoli; Helena Bauerova; Iva Pichova; Eric Hunter
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

3.  Virion envelope content, infectivity, and neutralization sensitivity of simian immunodeficiency virus.

Authors:  Eloísa Yuste; Welkin Johnson; George N Pavlakis; Ronald C Desrosiers
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

Review 4.  The tale of the long tail: the cytoplasmic domain of HIV-1 gp41.

Authors:  Thomas S Postler; Ronald C Desrosiers
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

5.  Reconstitution of the ancestral glycoprotein of human endogenous retrovirus k and modulation of its functional activity by truncation of the cytoplasmic domain.

Authors:  Kirsten Hanke; Philipp Kramer; Sandra Seeher; Nadine Beimforde; Reinhard Kurth; Norbert Bannert
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

Review 6.  Understanding the process of envelope glycoprotein incorporation into virions in simian and feline immunodeficiency viruses.

Authors:  José L Affranchino; Silvia A González
Journal:  Viruses       Date:  2014-01-16       Impact factor: 5.048

7.  Lentiviral Gag assembly analyzed through the functional characterization of chimeric simian immunodeficiency viruses expressing different domains of the feline immunodeficiency virus capsid protein.

Authors:  María J Esteva; José L Affranchino; Silvia A González
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

8.  Analysis of the functional compatibility of SIV capsid sequences in the context of the FIV gag precursor.

Authors:  César A Ovejero; José L Affranchino; Silvia A González
Journal:  PLoS One       Date:  2017-05-05       Impact factor: 3.240

9.  The Conserved Tyr176/Leu177 Motif in the α-Helix 9 of the Feline Immunodeficiency Virus Capsid Protein Is Critical for Gag Particle Assembly.

Authors:  César A Ovejero; Silvia A González; José L Affranchino
Journal:  Viruses       Date:  2019-09-04       Impact factor: 5.048

Review 10.  Properties and Functions of Feline Immunodeficiency Virus Gag Domains in Virion Assembly and Budding.

Authors:  Silvia A González; José L Affranchino
Journal:  Viruses       Date:  2018-05-16       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.